Teacher Retirement System Of Texas Allovir, Inc. Transaction History

Teacher Retirement System Of Texas

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 31, 2023	SELL	$2.15 - $3.64 $978 - $1,656	-455 Reduced 3.26%	13,508 $29,000
Q2 2023 Jul 19, 2023	SELL	$3.17 - $5.82 $1,226 - $2,252	-387 Reduced 2.7%	13,963 $47,000
Q1 2023 May 12, 2023	BUY	$3.94 - $7.05 $1,091 - $1,952	277 Added 1.97%	14,350 $57,000
Q4 2022 Feb 10, 2023	SELL	$4.7 - $9.98 $2,758 - $5,858	-587 Reduced 4.0%	14,073 $72,000
Q3 2022 Nov 03, 2022	BUY	$4.13 - $8.79 $60,545 - $128,861	14,660 New	14,660 $116,000

44.6M

14.9K

200

Ticker ALVR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,063,400
Market Cap $40.9M
Description
Allovir, Inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific T cell (VST) therapies to prevent and treat devastating viral-associated diseases. The company's lead product is posoleucel, an allogeneic, off-the-shelf VST therapy, to treat BK virus, cytomegalovirus, ...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.